Researchers at Moffitt Cancer Center, working with colleagues at The University of Arizona and Arizona State University, have developed a new combination agent approach targeting tumor receptors based on their variety of cell surface proteins. The approach, which was tested in pancreatic cancers and melanoma modeled in tumor-bearing mice, opens the possibility of developing new multivalent agents that can target unique and multiple receptor combinations in tumor cells. This is a significant improvement over current single-target strategies.
Recent PostsMonday, February 20, 2017
Consider it one physician’s giant leap for mankind. The latest rocket launch from NASA’s Kennedy Space Center in Cape Canaveral, Florida, included a payload of several samples of donated adult stem cells from a research laboratory at Mayo Clinic’s Florida campus. ..Read More ⇒Friday, February 17, 2017
Scientists at FIU Herbert Wertheim College of Medicine (HWCOM) are studying new therapies that can short circuit HIV infection and mitigate the damaging effects that opiate addiction has on the central nervous system. ..Read More ⇒Thursday, February 16, 2017
Keith Knutson, Ph.D., director of the Discovery and Translation Labs Cancer Research Program at Mayo Clinic’s campus in Florida, has received a $3.7 million grant from the U.S. Department of Defense to conduct a phase II clinical trial that will test a vaccine designed to establish lifelong immunity against development of these precancerous lesions. ..Read More ⇒Thursday, February 16, 2017
A University of Central Florida professor is working with NASA to figure out a way to extract metals from the Martian soil – metals that could be fed into a 3-D printer to produce the components of a human habitat, ship parts, tools and electronics. ..Read More ⇒Wednesday, February 15, 2017
A University of Central Florida professor has invented a way to use light to continuously monitor a surgical patient’s blood, for the first time providing a real-time status during life-and-death operations. ..Read More ⇒
Tagsresearch policy GrowFL biomedical health clean energy AxoGen awards animals ICFO commercialization Embry-Riddle medical materials science AGTC health care grants research green technology conference / event FL Institute for Commercialization of Public Research ecology Max Planck innovation VGTI Draper stem cell children partnerships environment engineering University of West Florida policy University of North Florida economy biotechnology consumers Enterprise Florida robotics Banyan Biomarkers Florida Hospital neuroscience University of Miami Nova Southeastern Univ. biochemistry Nanotheraputics education physics accounting Mayo Clinic Torrey Pines Institute HIV/AIDS Jackson Lab University of Central Florida energy BioFlorida accolades FAMU Florida International Univ. society/culture marine cancer Moffitt Cancer Center agriculture Florida Trend bioscience gender University of Florida photonics Florida Atlantic University sustainability accreditation aging Univeristy of South Florida Florida Power & Light Scripps Research Institute Florida State University Florida Gulf Coast Univ. Florida Institute of Technology nanotechnology technology business IHMC astronomy computer science sciences aerospace magnets Sanford-Burnham